Satterlee, Andrew B., Denise E. Dunn, Donald C. Lo, Simon Khagi, and Shawn Hingtgen. “Tumoricidal Stem Cell Therapy Enables Killing in Novel Hybrid Models of Heterogeneous Glioblastoma.” In Molecular Therapy, 27:165–165. CELL PRESS, 2019.
Lee, Han Kyu, Sehwon Koh, Donald C. Lo, and Douglas A. Marchuk. “Neuronal IL-4Rα modulates neuronal apoptosis and cell viability during the acute phases of cerebral ischemia..” Febs J 285, no. 15 (August 2018): 2785–98. https://doi.org/10.1111/febs.14498.
Shimada, Kenichi, Eduard Reznik, Michael E. Stokes, Lakshmi Krishnamoorthy, Pieter H. Bos, Yuyu Song, Christine E. Quartararo, et al. “Copper-Binding Small Molecule Induces Oxidative Stress and Cell-Cycle Arrest in Glioblastoma-Patient-Derived Cells..” Cell Chem Biol 25, no. 5 (May 17, 2018): 585-594.e7. https://doi.org/10.1016/j.chembiol.2018.02.010.
Satterlee, Andrew B., Denise E. Dunn, Shaye Hagler, Simon Khagi, Donald C. Lo, and Shawn Hingtgen. “Novel Heterogeneous Glioblastoma Models to Optimize Human Tumoricidal Stem Cell Therapy.” In Molecular Therapy, 26:65–65. CELL PRESS, 2018.
Dickey, Audrey S., Dafne N. Sanchez, Martin Arreola, Kunal R. Sampat, Weiwei Fan, Nicolas Arbez, Sergey Akimov, et al. “PPARδ activation by bexarotene promotes neuroprotection by restoring bioenergetic and quality control homeostasis..” Sci Transl Med 9, no. 419 (December 6, 2017). https://doi.org/10.1126/scitranslmed.aal2332.
Khoshnan, Ali, Adam Sabbaugh, Barbara Calamini, Steven A. Marinero, Denise E. Dunn, Jung Hyun Yoo, Jan Ko, Donald C. Lo, and Paul H. Patterson. “IKKβ and mutant huntingtin interactions regulate the expression of IL-34: implications for microglial-mediated neurodegeneration in HD..” Hum Mol Genet 26, no. 21 (November 1, 2017): 4267–77. https://doi.org/10.1093/hmg/ddx315.
Pirhaji, Leila, Pamela Milani, Simona Dalin, Brook T. Wassie, Denise E. Dunn, Robert J. Fenster, Julian Avila-Pacheco, et al. “Identifying therapeutic targets by combining transcriptional data with ordinal clinical measurements..” Nat Commun 8, no. 1 (September 20, 2017). https://doi.org/10.1038/s41467-017-00353-6.
Quinti, Luisa, Sharadha Dayalan Naidu, Ulrike Träger, Xiqun Chen, Kimberly Kegel-Gleason, David Llères, Colúm Connolly, et al. “KEAP1-modifying small molecule reveals muted NRF2 signaling responses in neural stem cells from Huntington's disease patients..” Proc Natl Acad Sci U S A 114, no. 23 (June 6, 2017): E4676–85. https://doi.org/10.1073/pnas.1614943114.
Gomez-Pastor, Rocio, Eileen T. Burchfiel, Daniel W. Neef, Alex M. Jaeger, Elisa Cabiscol, Spencer U. McKinstry, Argenia Doss, et al. “Abnormal degradation of the neuronal stress-protective transcription factor HSF1 in Huntington's disease..” Nat Commun 8 (February 13, 2017). https://doi.org/10.1038/ncomms14405.
Zhang, Zhiquan, Qing Ma, Bijal Shah, G Burkhard Mackensen, Donald C. Lo, Joseph P. Mathew, Mihai V. Podgoreanu, and Niccolò Terrando. “Neuroprotective Effects of Annexin A1 Tripeptide after Deep Hypothermic Circulatory Arrest in Rats..” Front Immunol 8 (2017). https://doi.org/10.3389/fimmu.2017.01050.